WEKO3
アイテム
A fatal case of COVID-19 pneumonia due to possible pulmonary thrombosis
http://hdl.handle.net/10069/00041280
http://hdl.handle.net/10069/000412804a22d8ad-bfea-4484-b508-fa095d337976
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
ActMed65_67.pdf (628.1 kB)
|
|
| Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2022-02-25 | |||||
| タイトル | ||||||
| タイトル | A fatal case of COVID-19 pneumonia due to possible pulmonary thrombosis | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | COVID-19 | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | coagulopathy | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | possible pulmonary thrombosis | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | hyperinflammation | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | departmental bulletin paper | |||||
| 著者 |
Yamashita, Koki
× Yamashita, Koki× Fukuda, Yuichi× Yoshikawa, Rokusuke× Tanaka, Yasuhiro× Yoshida, Masataka× Umemura, Asuka× Kobayashi, Tsutomu× Soda, Hiroshi× Yasuda, Jiro× Izumikawa, Koichi× Yanagihara, Katsunori× Mukae, Hiroshi× Kohno, Shigeru |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | The relationship between the severity of COVID-19, hyperinflammation, and intravascular oagulopathy is of critical importance. We report on a case of severe COVID-19 pneumonia treated with favipiravir during the earliest phase of the pandemic. The present case showed improvement in SARS-CoV-2 viral load and the presence of SARS-CoV-2 IgG with decreased radiological evidence of pulmonary infiltration. Moreover, the levels of serum IL-6 and TNF-α did not increase markedly. However, the hypoxia failed to recover, leading to the patient’s death due to possible pulmonary thrombosis, because D-dimer was markedly elevated, and an electrocardiogram showed typical changes. At present, the fact that some COVID-19 patients with mild to moderate symptoms suddenly die at home has become a major issue in Japan. These findings suggest that additional treatment with anti-coagulants should be considered in some COVID-19 patients at risk of ypercoagulation to prevent sudden death from pulmonary thrombosis. | |||||
| 書誌情報 |
Acta medica Nagasakiensia 巻 65, 号 2, p. 67-71, 発行日 2022-01 |
|||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 00016055 | |||||
| 書誌レコードID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AA00508430 | |||||
| 著者版フラグ | ||||||
| 出版タイプ | VoR | |||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
| 出版者 | ||||||
| 出版者 | Nagasaki University School of Medicine | |||||
| 出版者別言語 | ||||||
| 値 | 長崎大学医学部 | |||||
| sortkey | ||||||
| 値 | 06 | |||||
| 引用 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | Acta medica Nagasakiensia, 65(2), pp.67-71; 2022 | |||||
